Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma Research Letter
| Authors: | Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; Markova, A. |
| Title: | Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma |
| Keywords: | adult; cancer chemotherapy; clinical article; human tissue; aged; middle aged; lenalidomide; prednisone; cancer combination chemotherapy; drug dose reduction; antineoplastic agent; letter; multiple cycle treatment; multiple myeloma; antineoplastic combined chemotherapy protocols; interleukin 5; dexamethasone; steroid; retrospective study; monoclonal antibody; loading drug dose; rash; maculopapular rash; interleukin 6; hydrocortisone; tacrolimus; leukemia relapse; autologous hematopoietic stem cell transplantation; carfilzomib; exanthema; clobetasol; triamcinolone; immunoglobulin e; pregabalin; fluocinonide; complication; eosinophil count; eosinophilia; alclometasone; antibodies, monoclonal, humanized; humans; human; male; female; daratumumab; dupilumab |
| Journal Title: | Leukemia and Lymphoma |
| Volume: | 63 |
| Issue: | 9 |
| ISSN: | 1042-8194 |
| Publisher: | Taylor & Francis Group |
| Date Published: | 2022-01-01 |
| Start Page: | 2233 |
| End Page: | 2237 |
| Language: | English |
| DOI: | 10.1080/10428194.2022.2068002 |
| PUBMED: | 35532206 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 November 2022 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
